Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-15

Clinical Trial Update: Trial of Best Supportive Care and Either Cisplatin or Paclitaxel to Treat Patients With Primary Ovarian Cancer, Primary Peritoneal Cancer or Fallopian Tube Cancer and Inoperable Malignant Bowel Obstruction [Phase 1, Phase 2]

View source ↗

Summary

This Phase 1/2 clinical trial tests best supportive care with either cisplatin or paclitaxel for patients with ovarian cancer, primary peritoneal cancer, or fal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CISPLATIN (cisplatin)
  • PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Ovarian Cancer, Peritoneal Cancer | Phase 1, Phase 2 | Status: TERMINATED